Deactivation of the lipopolysaccharide antagonist eritoran (E5564) by high-density lipoprotein-associated apolipoproteins.

about

Proteomics mapping of cord blood identifies haptoglobin "switch-on" pattern as biomarker of early-onset neonatal sepsis in preterm newborns Conformationally constrained lipid A mimetics for exploration of structural basis of TLR4/MD-2 activation by lipopolysaccharide.

P2860

Q28744089-064E3832-C20D-41B9-A48A-5BD51A09DEF3 Q37323250-4846FBA5-E856-4154-B6CF-86058E189E7D

P2860

Deactivation of the lipopolysaccharide antagonist eritoran (E5564) by high-density lipoprotein-associated apolipoproteins.

Item

http://www.wikidata.org/entity/Q38336848

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh

2011年學術文章

@zh-hant

name

Deactivation of the lipopolysa ...... in-associated apolipoproteins.

@en

type

Item

label

Deactivation of the lipopolysa ...... in-associated apolipoproteins.

@en

prefLabel

Deactivation of the lipopolysa ...... in-associated apolipoproteins.

@en

P1476

Deactivation of the lipopolysa ...... in-associated apolipoproteins.

@en

P2093

Dan Rossignol

http://www.w3.org/2001/XMLSchema#string

Gordon A Francis

http://www.w3.org/2001/XMLSchema#string

Jacklyn G Fleischer

http://www.w3.org/2001/XMLSchema#string

Kishor M Wasan

http://www.w3.org/2001/XMLSchema#string

Melvyn Lynn

http://www.w3.org/2001/XMLSchema#string

Teddy Chan

http://www.w3.org/2001/XMLSchema#string

P2860

Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene

Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine

Enhanced cholesterol efflux by tyrosyl radical-oxidized high density lipoprotein is mediated by apolipoprotein AI-AII heterodimers

Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care

Impact of lipoproteins on the biological activity and disposition of hydrophobic drugs: implications for drug discovery

Structure and evolution of the apolipoprotein multigene family

Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin

Influence of apoA-I and apoE on the formation of serum amyloid A-containing lipoproteins in vivo and in vitro

Inhibition of endotoxin response by e5564, a novel Toll-like receptor 4-directed endotoxin antagonist.

Inhibition of endotoxin response by synthetic TLR4 antagonists.

P304

171-178

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1753425910394395

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2011-03-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

50304054

http://www.w3.org/2001/XMLSchema#string

P698

21382909

http://www.w3.org/2001/XMLSchema#string

P921

lipoprotein

lipopolysaccharide

eritoran

Deactivation of the lipopolysaccharide antagonist eritoran (E5564) by high-density lipoprotein-associated apolipoproteins.

about

P2860

P2860

Deactivation of the lipopolysaccharide antagonist eritoran (E5564) by high-density lipoprotein-associated apolipoproteins.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921